Contemporary management of muscle-invasive bladder cancer

International Journal of Clinical Oncology

Volumn 13, Issue 6, 2008, Pages 504-509

  Yafi, Faysal A ^a   Steinberg, Jordan R ^a   Kassouf, Wassim ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cystectomy; Invasive bladder cancer; Management; Multimodal; Outcome

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; VINBLASTINE;

ADJUVANT THERAPY; BLADDER CANCER; BLADDER CARCINOMA; BLADDER PRESERVATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; HUMAN; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; MUSCLE INVASIVE UROTHELIAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE;

HUMANS; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 57849094598     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0788-9     Document Type: Review

References (50)

1. A. Jemal R. Siegel E. Ward 2007 Cancer statistics CA Cancer J Clin 57 106 130
2. A. Morrison 1984 Advances in the etiology of urothelial cancer Urol Clin North Am 11 557 566
3. S. Jankovic V. Radosavljevic 2007 Risk factors for bladder cancer Tumori 93 1 12
4. R. Millikan C. Dinney D. Swanson 2001 Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC J Clin Oncol 19 4005 4013
5. R.D. Ennis D.P. Petrylak P. Singh 2000 The effect of cystectomy and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer J Urol 163 1413 1418
6. M.L. Quek J.P. Stein P.W. Nichols 2005 Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy J Urol 174 103 106
7. Y. Horikawa T. Kumazawa S. Narita 2007 Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy Int J Clin Oncol 12 131 136
8. J. Leissner C. Koeppen H.K. Wolf 2003 Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy J Urol 169 955 960
9. J. Stein G. Lieskovsky R. Cote 2001 Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients J Clin Oncol 19 666 675
10. D.J. Rosario M. Becker J.B. Anderson 2000 The changing pattern of mortality and morbidity from radical cystectomy BJU Int 85 427 430
11. M. Quek J. Stein S. Daneshmand 2006 A critical analysis of perioperative mortality from radical cystectomy J Urol 175 886 889
12. World Health Organization R. Hautmann H. Abol-Enein K. Hafez 2007 Urinary diversion Urology 69 17 49
13. T. Kessler 2004 Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution J Urol 172 1323 1327
14. J. Stein P. Clark G. Miranda 2005 Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients J Urol 173 1163 1168
15. A. Stenzl H. Draxl B. Posch 1995 The risk of urethral tumors in female bladder cancer: can the urethra be used for orthotopic reconstruction of the lower urinary tract? J Urol 153 950 955
16. G. Raj R. Tal A. Vickers 2006 Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer Cancer 107 2167 2172
17. M. Schumacher M. Scholz E. Weise 2006 Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol 176 2409 2413
18. S. Madersbacher W. Hochreiter F. Burkhard 2003 Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy J Clin Oncol 21 690 696
19. J. Leissner M. Ghoneim H. Abol-Enein 2004 Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study J Urol 171 139 144
20. J. Leissner R. Hohenfellner J. Thüroff 2000 Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis BJU Int 85 817 883
21. H. Herr 2007 The concept of lymph node density - is it ready for clinical practice? J Urol 177 1273 1275
22. J. Stein D. Skinner 2005 The role of lymphadenectomy in high-grade invasive bladder cancer Urol Clin North Am 32 187 197
23. W. Kassouf D. Leibovici M. Munsell 2006 Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy J Urol 176 53 57
24. W. Kassouf P.K. Aqarwal H.W. Herr 2008 Lymph node density is superior to TNM nodal status in predicting diseasespecific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC J Clin Oncol 26 121 126
25. H. Herr J. Faulkner H. Grossman 2004 Surgical factors influence bladder cancer outcomes: a cooperative group report J Clin Oncol 22 2781 2789
26. International Collaboration of Trialists 1999 Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial Lancet 14 533 540
27. A. Sherif E. Rintala O. Mestad 2002 Neoadjuvant cisplatinmethotrexate chemotherapy for invasive bladder cancer - Nordic cystectomy trial 2 Scand J Urol Nephrol 36 419 425
28. C. ABCAM-a 2005 Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data; Advanced Bladder Cancer (ABC) Metaanalysis Collaboration Eur Urol 48 202 205
29. H. Grossman R. Natale C. Tangen 2003 Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 859 866
30. F. Freiha J.F.T. Reese 1996 A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer J Urol 155 495 499
31. M. Stöckle W. Meyenburg S. Wellek 1992 Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and three adjuvant cycles of chemotherapy J Urol 148 302 307
32. D. Skinner J. Daniels C. Russell 1991 The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J Urol 145 459 464
33. C. ABCAM-a 2005 Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data; Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 189 199
34. W. Kassouf P. Spiess G. Brown 2007 P0 Stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors Eur Urol 52 769 776
35. H. Herr 1998 Transurethral resection of muscle-invasive bladder cancer: 10-year outcome J Clin Oncol 19 89 93
36. W. Kassouf D. Swanson A. Kamat 2006 Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience J Urol 175 2058 2062
37. H. Herr D. Bajorin H. Scher 1998 Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: 10-year outcome J Clin Oncol 16 1298 1301
38. M. Milosevic M. Gospodarowicz A. Zietman 2007 Radiotherapy for bladder cancer Urology 69 80 92
39. W. Duncan P. Quilty 1986 The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy Radiother Oncol 7 299 310
40. W. Shipley D. Kaufman E. Zehr 2002 Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer Urology 60 62 67
41. M. Housset C. Maulard Y. Chretien 1993 Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study J Clin Oncol 11 2150 2157
42. C. Rödel G. Grabenbauer R. Kühn 2002 Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results J Clin Oncol 20 3061 3071
43. N. Miyanaga H. Akaza S. Hinotsu 2007 Background variables for the patients with invasive bladder cancer suitable for bladder-preserving therapy Jpn J Clin Oncol 37 852 857
44. P. Bassi F. Pagano G. Pappagallo 1998 Neoadjuvant M-VAC of invasive bladder cancer: the G.U.O.N.E. multicenter phase III trial Eur Urol 33 142
45. GISTV 1996 Neoadjuvant treatment for locally advanced bladder cancer: a randomized prospective clinical trial J Chemother 8 345 346
46. M. Orsatti A. Curotto L. Canobbio 1995 Altering chemo-radiotherapy in bladder cancer: a conservative approach Int J Radiat Oncol Biol Phys 33 173 178
47. H. Abol-Enein M. El Makresh M. El Baz 1997 Neoadjuvant chemotherapy in treatment of invasive transitional bladder cancer: a controlled, prospective randomized study Br J Urol 80 49
48. A.V. Bono C. Benvenuti A. Gibba 1997 Adjuvant chemotherapy in locally advanced bladder cancer: final analysis of a controlled multicentre study Acta Urol Ital 11 5 8
49. U.E. Studer M. Bacchi C. Biedermann 1994 Adjuvant cisplatin chemotherapy following cystectomy for bladder cancers: results of a prospective randomized trial J Urol 152 81 84
50. T. Otto C. Börgemann S. Krege 2001 Adjuvant chemotherapy in locally advanced bladder cancer (PT3/PN1-2, M0) - a phase III study Eur Urol 39 147